Figure 1From: Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study Cognitive domain scores. The cognitive domain scores (standardized Z values) for the patients using VEGFR TKI, the patient controls and the healthy controls. Post-hoc t-tests, patient groups compared to healthy controls: *P < 0.05, **P < 0.01, ***P < 0.001.Back to article page